193 related articles for article (PubMed ID: 29562956)
1. TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis.
Hu G; Pen W; Wang M
Oncol Res; 2019 Mar; 27(4):439-447. PubMed ID: 29562956
[TBL] [Abstract][Full Text] [Related]
2. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.
Sun W; Wang Y; Li D; Wu Y; Ji Q; Sun T
Biochem Biophys Res Commun; 2020 Jan; 521(2):360-367. PubMed ID: 31668806
[TBL] [Abstract][Full Text] [Related]
3. TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways.
Chen J; Huang L; Quan J; Xiang D
Aging (Albany NY); 2021 May; 13(9):13225-13238. PubMed ID: 33982666
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.
Diao W; Zhu C; Guo Q; Cao Y; Song Y; Feng H; Li J; Xue X; Lu P
Mol Med Rep; 2020 Dec; 22(6):5145-5154. PubMed ID: 33174608
[TBL] [Abstract][Full Text] [Related]
5. TRIM14 Overexpression Induces Chemoresistance and Malignant Behaviors of Hepatocellular Carcinoma Cells by Activating the STAT3/HIF-1α Pathway.
Xu W; Zhuang L; Zhu H; Mao A; Zhou J; Wang L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628777
[TBL] [Abstract][Full Text] [Related]
6. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
7. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
8. Expression of the human TRIM14 and its mutant form (P207L) promotes apoptosis in transgenic loaches.
Nenasheva VV; Stepanenko EA; Makarova IV; Khaidarova NV; Antonov SA; Kozikova LV; Polteva EA; Kovaleva GV; Ayed Z; Vovk AD; Shcherbatova NA; Andreeva LE; Tarantul VZ
Mol Biol Rep; 2018 Dec; 45(6):2087-2093. PubMed ID: 30203243
[TBL] [Abstract][Full Text] [Related]
9. TRIM14 Is a Key Regulator of the Type I IFN Response during
Hoffpauir CT; Bell SL; West KO; Jing T; Wagner AR; Torres-Odio S; Cox JS; West AP; Li P; Patrick KL; Watson RO
J Immunol; 2020 Jul; 205(1):153-167. PubMed ID: 32404352
[TBL] [Abstract][Full Text] [Related]
10. Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.
Feng S; Cai X; Li Y; Jian X; Zhang L; Li B
J Exp Clin Cancer Res; 2019 Feb; 38(1):57. PubMed ID: 30728039
[TBL] [Abstract][Full Text] [Related]
11. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
Wang F; Ruan L; Yang J; Zhao Q; Wei W
Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.
Su X; Wang J; Chen W; Li Z; Fu X; Yang A
Oncotarget; 2016 Mar; 7(9):9939-50. PubMed ID: 26799420
[TBL] [Abstract][Full Text] [Related]
13. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
15. TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer.
Shen W; Jin Z; Tong X; Wang H; Zhuang L; Lu X; Wu S
Cancer Manag Res; 2019; 11():5725-5735. PubMed ID: 31296997
[TBL] [Abstract][Full Text] [Related]
16. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
17. TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway.
Jin Z; Li H; Hong X; Ying G; Lu X; Zhuang L; Wu S
Cancer Cell Int; 2018; 18():202. PubMed ID: 30555277
[TBL] [Abstract][Full Text] [Related]
18. TRIM14 expression is regulated by IRF-1 and IRF-2.
Cui J; Xu X; Li Y; Hu X; Xie Y; Tan J; Qiao W
FEBS Open Bio; 2019 Aug; 9(8):1413-1420. PubMed ID: 31150153
[TBL] [Abstract][Full Text] [Related]
19. TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.
Hai J; Zhu CQ; Wang T; Organ SL; Shepherd FA; Tsao MS
Sci Rep; 2017 Jan; 7():39692. PubMed ID: 28059079
[TBL] [Abstract][Full Text] [Related]
20. TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2.
Tan Z; Song L; Wu W; Zhou Y; Zhu J; Wu G; Cao L; Song J; Li J; Zhang W
Oncogene; 2018 Oct; 37(40):5403-5415. PubMed ID: 29867201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
